About us Company outline
기업 개요
COMPANY OUTLINE
iYoung, Inc. is focusing on two business areas with the goal of treating metabolic diseases. The first is the development of diabetes treatment using several types of human stem cells (e.g., ESC, iPSC, and MSC), and the second is the development of a new metabolic dysfunction-associated steatohepatitis (MASH) first-in-class drug.
iYoung, Inc. is focusing on two business areas with the goal of treating metabolic diseases. The first is the development of diabetes treatment using several types of human stem cells (e.g., ESC, iPSC, and MSC), and the second is the development of a new metabolic dysfunction-associated steatohepatitis (MASH) first-in-class drug.
기업 연혁
COMPANY HISTORY TIMELINE
2024 04
2024 06
2024 07
Foundation of iYoung, Inc.
The 5th BCC in 2024; FMI's 5th Bio-health Innovation Competition, Selection of Outstanding Companies
Certification of Research Institute
